Categories AlphaGraphs, Earnings, Health Care
Earnings: Intuitive Surgical (ISRG) Q3 results exceed estimates
Intuitive Surgical Inc. (NASDAQ: ISRG) reported lower earnings and revenues for the third quarter of 2020, hurt by the coronavirus-related disruption. However, the results topped the Street view.
The top-line dropped 4% annually to $1.08 billion during the three-month period, despite an increase in the flagship da Vinci procedures. At $2.77 per share, adjusted earnings were down 19% year-over-year.
Net income declined to $314 million or $2.60 per share from $397 million or $3.33 per share in the third quarter of 2019. During the quarter, operations were disrupted by the pandemic and procedure volumes remained below the normal levels.
Read management/analysts’ comments on Intuitive Surgical’s Q3 results
Shares of Intuitive Surgical closed Thursday’s regular session lower. The stock has gained 27% since the beginning of the year.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
